ON-DEMAND Managing CVD risk in type 2 diabetes | Diabetes on the Net

Your web browser is out of date.

For your security and improved experience online, please update your browser.

Diabetes on the Net is intended for healthcare professionals

This video was originally broadcast on 23 June 2020. Please note that the speakers are not able to answer questions from attendees watching the video on-demand.

Managing CVD risk in type 2 diabetes


  • Naresh Kanumilli, GPSi in Diabetes and Cardiology, Manchester
  • Nicola Milne, Community Diabetes Specialist Nurse, Manchester


Date of session: 23 June 2020


Managing cardiovascular disease risk in type 2 diabetes


  1. Buse JB et al (2020) Diabetologia 63: 221−28.
  2. Evert AB et al (2019) Diabetes Care 42: 731–54.
  3. Diabetes UK (2018) Evidence-based nutrition guidelines for the prevention and management of diabetes. Diabetes UK, London.
  4. Holman RR et al (2008) N Engl J Med 359: 1565–76.
  5. Aroda VR et al (2017) Diabetologia 60: 1601–11.


View the presentation delivered by Dr. Naresh Kanumilli & Nicola Milne as they examine the following topics:

1. CV risk factors and their long-term outcome.

2. EASD/ADA update

    • Overview of the 2020 guidance
    • Impact on primary care

3. Translating CVOT data into primary care management

    • Interpreting CVOTs for everyday practice
This independent programme has been funded by AstraZeneca. AstraZeneca has had no editorial input into, or control over the content. PCDS is responsible for the content of all materials and selection of speakers pertaining to this.

Practical experiences from running an adeno-associated virus gene therapy trials: The Principal Investigator’s perspective

XX September 2020

Complete the registration form

XX Month 2020

Complete the registration form

We use cookies to ensure that we give you the best experience on our website. Some may have been set already. If you continue without changing your settings, we’ll assume that you are happy to receive all cookies on this website. Read about how we use cookies. If you have any concerns about this, please click here to find out more.

* Mandatory Field
Your data is being collected by OmniaMed Communications on behalf of Novo Nordisk solely for the purpose of processing your registration. Your details will not be shared with any parties other than OmniaMed Communications and Novo Nordisk.